NCT07004140 Proving Utility of a New Field-cycling MRI Prototype in Acute Stroke Patients
| NCT ID | NCT07004140 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Aberdeen |
| Condition | Stroke Acute |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-09-16 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-09-16 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can show changes in the brain within the first day of a stroke due to a blocked blood vessel or bleeding in the brain. The main question it aims to answer is: • Can FCI identify brain tissue that might recover within the first few hours after a stroke begins? Participants will undergo a standard MRI scan and an FCI scan, as soon as possible after hospital admission. Participants who have had a blocked blood vessel will also provide a blood sample and will have a follow up visit at 30 days for repeat of both scans and providing another blood sample.
Eligibility Criteria
Inclusion Criteria: * Acute stroke (\<24 hours from symptom onset). * NIHSS ≥4 and \<25 with cortical involvement and/or large vessel occlusion on baseline imaging. * Able to undergo 3T and FCI MRI \<24h of onset. * With or without thrombolysis. Exclusion Criteria: * Contraindications to MRI. * Medically unstable. * Unable to comprehend or comply with instructions regarding scanning * Prior mRS of \>3. * Identified for thrombectomy. * Non-stroke pathology or previous cortical infarct on CT scan \> 1/3 of middle cerebral artery territory.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07004140 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07004140 currently recruiting?
Yes, NCT07004140 is actively recruiting participants. Contact the research team at m.j.macleod@abdn.ac.uk for enrollment information.
Where is the NCT07004140 trial being conducted?
This trial is being conducted at Aberdeen, United Kingdom.
Who is sponsoring the NCT07004140 clinical trial?
NCT07004140 is sponsored by University of Aberdeen. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.